Form 8-K - Current report:
SEC Accession No. 0001140361-21-039055
Filing Date
2021-11-23
Accepted
2021-11-23 08:00:37
Documents
12
Period of Report
2021-11-23
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K brhc10031137_8k.htm   iXBRL 8-K 28143
  Complete submission text file 0001140361-21-039055.txt   165091

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA btx-20211123.xsd EX-101.SCH 3929
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE btx-20211123_lab.xml EX-101.LAB 22544
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE btx-20211123_pre.xml EX-101.PRE 16047
5 EXTRACTED XBRL INSTANCE DOCUMENT brhc10031137_8k_htm.xml XML 4246
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-11460 | Film No.: 211434711
SIC: 2834 Pharmaceutical Preparations